Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

American Oriental Reports Higher Revenue, Lower Profit in Q1

publication date: May 11, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

American Oriental Bioengineering (广西博科药业) reported mixed results for its first quarter. Revenue increased 19% from the year-earlier quarter to $46.1 million, but net income fell 16% to $7.9 million. American Oriental commented that $1.7 million in interest expense for newly issued convertible bonds was the major difference: increased interest expense changed the comparison with 2008’s Q1 from flat to lower. More details...

Stock Symbol: (NYSE: AOB)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...